Fluoguide A/S is a biotechnology company focused on the innovative design and development of products that improve surgical outcomes. Primarily, the company specializes in the field of fluorescence-guided surgery, aiming to enhance the precision and safety of surgical procedures. The technology developed by Fluoguide A/S is particularly impactful in the healthcare sector, offering tools that allow surgeons to differentiate between healthy and cancerous tissues more effectively. This potentially increases the likelihood of complete tumor removal while minimizing damage to surrounding healthy tissue. Founded with the goal of advancing surgical techniques, Fluoguide A/S plays a significant role in the medical technology market by driving forward solutions that address critical needs in cancer treatment and surgical procedures. The company's advancements support the global push towards more precise, minimally invasive medical interventions, marking Fluoguide A/S as a key player in the sector's ongoing evolution.